Advanced Change In Cash from 2010 to 2026

ADVB Stock   0.28  0.03  10.68%   
Advanced Biomed's Change In Cash is increasing over the years with very volatile fluctuation. Change In Cash is expected to dwindle to about 16.3 K. From 2010 to 2026 Advanced Biomed Change In Cash quarterly data regression line had arithmetic mean of  152,755 and r-squared of  0. View All Fundamentals
 
Change In Cash  
First Reported
2010-12-31
Previous Quarter
17.1 K
Current Value
16.3 K
Quarterly Volatility
1.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Advanced Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 64.6 K or Interest Income of 64.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0048. Advanced financial statements analysis is a perfect complement when working with Advanced Biomed Valuation or Volatility modules.
  
Build AI portfolio with Advanced Stock
Check out the analysis of Advanced Biomed Correlation against competitors.

Latest Advanced Biomed's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Advanced Biomed Common over the last few years. It is Advanced Biomed's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Advanced Biomed's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Very volatile
   Change In Cash   
       Timeline  

Advanced Change In Cash Regression Statistics

Arithmetic Mean152,755
Geometric Mean1,862
Coefficient Of Variation843.07
Mean Deviation537,081
Median217.00
Standard Deviation1,287,825
Sample Variance1.7T
Range6.9M
R-Value0.06
Mean Square Error1.8T
R-Squared0
Significance0.83
Slope14,198
Total Sum of Squares26.5T

Advanced Change In Cash History

202616.3 K
202517.1 K
202419 K
2023-14.3 K
2022-2.2 M
20214.7 M

About Advanced Biomed Financial Statements

Advanced Biomed stakeholders use historical fundamental indicators, such as Advanced Biomed's Change In Cash, to determine how well the company is positioned to perform in the future. Although Advanced Biomed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Advanced Biomed's assets and liabilities are reflected in the revenues and expenses on Advanced Biomed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Advanced Biomed Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Cash17.1 K16.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:
Check out the analysis of Advanced Biomed Correlation against competitors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Advanced Biomed assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.17)
Return On Assets
(0.35)
Return On Equity
(1.65)
Understanding Advanced Biomed Common requires distinguishing between market price and book value, where the latter reflects Advanced's accounting equity. The concept of intrinsic value—what Advanced Biomed's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Advanced Biomed's price substantially above or below its fundamental value.
Understanding that Advanced Biomed's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Advanced Biomed represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Advanced Biomed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.